Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
175,611,455
-
Total 13F shares
-
128,213,716
-
Share change
-
+2,558,188
-
Total reported value
-
$2,762,470,436
-
Put/Call ratio
-
59%
-
Price per share
-
$21.55
-
Number of holders
-
425
-
Value change
-
+$64,064,682
-
Number of buys
-
158
-
Number of sells
-
215
Institutional Holders of Teladoc Health, Inc. - Common Stock, par value $0.001 per share (TDOC) as of Q4 2023
As of 31 Dec 2023,
Teladoc Health, Inc. - Common Stock, par value $0.001 per share (TDOC) was held by
425 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
128,213,716 shares.
The largest 10 holders included
ARK Investment Management LLC, VANGUARD GROUP INC, BlackRock Inc., Sumitomo Mitsui Trust Holdings, Inc., Nikko Asset Management Americas, Inc., STATE STREET CORP, RENAISSANCE TECHNOLOGIES LLC, DIMENSIONAL FUND ADVISORS LP, MORGAN STANLEY, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
426
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.